The case for hedge funds in the throes of a crisis

clock • 2 min read

Against the backdrop of financial markets across the world falling steeply in the wake of the Covid-19 pandemic, investors rushed to traditional safe havens in a bid to safeguard their investments

Comparing the current crisis to previous market corrections, it is worth recalling the collateral benefits of investing in hedge funds. A hedge fund constitutes an investment programme whereby the managers or partners seek absolute returns by exploiting investment opportunities, while protecting principal from potential financial loss. Hence, the first hedge fund was a hedged fund. As of the end of March, leading stock market indices lost in a range of between 13% -20% of their total value, with the MSCI World index (a popular equities proxy used to compare hedge fund performance) los...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot